This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2000 Aug 3;343(5):365-6.

doi: 10.1056/NEJM200008033430512.

Liver damage due to alendronate

A Halabe, B M Lifschitz, J Azuri

PMID: 10928896
DOI: 10.1056/NEJM200008033430512

Case Reports

Liver damage due to alendronate

A Halabe et al. N Engl J Med. 2000.

. 2000 Aug 3;343(5):365-6.

doi: 10.1056/NEJM200008033430512.

Authors

A Halabe, B M Lifschitz, J Azuri

PMID: 10928896
DOI: 10.1056/NEJM200008033430512

No abstract available

PubMed Disclaimer

Comment on

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG. Saag KG, et al. N Engl J Med. 1998 Jul 30;339(5):292-9. doi: 10.1056/NEJM199807303390502. N Engl J Med. 1998. PMID: 9682041 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information